We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
-3.24%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$104M
AUM Growth
-$6.47M
Cap. Flow
-$1.26M
Cap. Flow %
-1.2%
Top 10 Hldgs %
22.84%
Holding
65
New
3
Increased
2
Reduced
55
Closed
3

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$2.01M
2
UNM icon
Unum
UNM
+$1.83M
3
SIRI icon
SiriusXM
SIRI
+$1.28M
4
BMY icon
Bristol-Myers Squibb
BMY
+$387K
5
PFG icon
Principal Financial Group
PFG
+$233K

Sector Composition

Rank Sector Weight
1 Financials 25.22%
2 Healthcare 13.21%
3 Industrials 11.88%
4 Technology 9.53%
5 Energy 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
26
Qualcomm
QCOM
$172B
$1.78M 1.7%
11,566
-288
-2% -$47.1K
PFG icon
27
Principal Financial Group
PFG
$24.1B
$1.77M 1.7%
22,900
+2,760
+14% +$233K
ELV icon
28
Elevance Health
ELV
$85.6B
$1.77M 1.7%
+4,803
New +$2.01M
AMGN icon
29
Amgen
AMGN
$225B
$1.77M 1.69%
6,790
-166
-2% -$49.3K
CSCO icon
30
Cisco
CSCO
$479B
$1.73M 1.66%
29,223
-731
-2% -$41.7K
SJM icon
31
J.M. Smucker
SJM
$12.6B
$1.73M 1.65%
15,672
-384
-2% -$44.2K
UPS icon
32
United Parcel Service
UPS
$89.2B
$1.72M 1.65%
13,654
-339
-2% -$44.6K
CVX icon
33
Chevron
CVX
$384B
$1.69M 1.61%
11,644
-289
-2% -$44.2K
TXN icon
34
Texas Instruments
TXN
$260B
$1.68M 1.61%
8,967
-225
-2% -$45K
NXST icon
35
Nexstar Media Group
NXST
$5.76B
$1.66M 1.59%
10,534
-265
-2% -$44.5K
UL icon
36
Unilever
UL
$134B
$1.66M 1.59%
26,043
-649
-2% -$43.8K
EOG icon
37
EOG Resources
EOG
$74.5B
$1.65M 1.58%
13,448
-338
-2% -$43.2K
O icon
38
Realty Income
O
$58.5B
$1.65M 1.58%
30,828
-766
-2% -$44.6K
PSX icon
39
Phillips 66
PSX
$87.4B
$1.58M 1.51%
13,847
-343
-2% -$43.6K
HSY icon
40
Hershey
HSY
$36.7B
$1.52M 1.45%
8,974
-223
-2% -$40K
BMY icon
41
Bristol-Myers Squibb
BMY
$131B
$1.5M 1.44%
26,501
+6,921
+35% +$387K
TD icon
42
Toronto Dominion Bank
TD
$201B
$1.37M 1.31%
25,691
-652
-2% -$36.6K
TRP icon
43
TC Energy
TRP
$66.9B
$1.36M 1.3%
29,237
-740
-2% -$35K
CCI icon
44
Crown Castle
CCI
$31.5B
$1.33M 1.28%
14,702
-372
-2% -$38.9K
CMCSA icon
45
Comcast
CMCSA
$89.7B
$1.33M 1.27%
35,467
-880
-2% -$36.5K
BBY icon
46
Best Buy
BBY
$17.8B
$1.32M 1.26%
15,384
-381
-2% -$34.8K
LYB icon
47
LyondellBasell Industries
LYB
$20.5B
$1.29M 1.24%
17,419
-437
-2% -$36.7K
EMN icon
48
Eastman Chemical
EMN
$8.55B
$1.27M 1.22%
13,948
-345
-2% -$35.4K
GPC icon
49
Genuine Parts
GPC
$18.7B
$1.22M 1.17%
10,437
-261
-2% -$32.6K
MPC icon
50
Marathon Petroleum
MPC
$92B
$1.21M 1.16%
8,657
-215
-2% -$32.8K

Similar funds

Weaver C. Barksdale & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Weaver C. Barksdale & Associates held 65 positions worth $104M, down 5.8% from $111M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Weaver C. Barksdale & Associates's Q4 2024 filing shows 3 new, 2 increased, 55 reduced and 3 closed positions. Its largest new stake was Elevance Health: 4,803 shares worth $1.77M. The largest sale was Interpublic Group of Companies, an estimated $1.56M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q4 2024 buy was Elevance Health: 4,803 shares worth $1.77M.
  • Weaver C. Barksdale & Associates added most to Bristol-Myers Squibb in Q4 2024, an estimated $387K increase.
  • Weaver C. Barksdale & Associates's biggest Q4 2024 reduction was Broadcom, cutting an estimated $734K.
  • Weaver C. Barksdale & Associates fully exited Interpublic Group of Companies in Q4 2024, selling an estimated $1.56M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 23% of its $104M portfolio in Q4 2024.
  • Weaver C. Barksdale & Associates opened 3 new positions and closed 3 in Q4 2024.
  • Weaver C. Barksdale & Associates's portfolio value fell 5.8% quarter-over-quarter to $104M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.